
Effect of Enteral Nutrition on In-hospital Infection and Hospital Expense in Stroke Patients: A Retrospective Assessment
Author(s) -
Hidetaka Onodera,
Takuma Mogamiya,
Shigeru Matsushima,
Taigen Sase,
Homare Nakamura,
Yohtaro Sakakibara
Publication year - 2021
Publication title -
neurologia medico-chirurgica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.788
H-Index - 51
eISSN - 1349-8029
pISSN - 0470-8105
DOI - 10.2176/nmc.oa.2020-0350
Subject(s) - medicine , parenteral nutrition , incidence (geometry) , stroke (engine) , enteral administration , body mass index , complication , retrospective cohort study , antibiotics , surgery , mechanical engineering , physics , microbiology and biotechnology , optics , biology , engineering
Infection is a common complication of stroke and is associated with unfavorable outcomes. Although nutritional intervention reduces the risk of postoperative infection, the impact of specific nutritional products remains unclear. From a hospital management perspective, we aimed to determine whether the provision of specific types of enteral nutrition in acute stroke patients affects infection control and hospital costs. In all, 45 acute hemorrhagic stroke patients receiving enteral nutrition in a single center (April 2017-March 2019) were retrospectively assessed. Patients were divided into two groups according to nutritional interventions: the 1.0-group with general nutrition (1.0 kcal/mL) (24 patients) and the 1.5+α-group with an initial high-protein, whey peptide-digested liquid diet (1.5 kcal/mL), followed by a highly fermentable fiber-containing liquid diet (1.5 kcal/mL initiated after 4 days) (21 patients). Changes in body mass index (BMI), duration of antibiotic use, incidence of postoperative infection, and medical cost were evaluated. Baseline patient characteristics were similar between groups. The mean BMI change was lower in the 1.5+α-group than in the 1.0-group, and the mean duration of antibiotic use throughout hospitalization was 12.8 and 18.3 days, respectively. Antibiotic use in the 1.5+α-group was lesser than that in Japanese patients from other hospitals. The incidence of postoperative infections was lower in the 1.5+α-group. Injection costs for the 1.5+α group (615 USD/patient) were lower than those for the 1.0-group. Enteral nutrition provided to acute stroke patients reduced the risk of hospital infection and medical costs.